Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C40H80NO8P |
| Molecular Weight | 734.0389 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC
InChI
InChIKey=KILNVBDSWZSGLL-KXQOOQHDSA-N
InChI=1S/C40H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-39(42)46-36-38(37-48-50(44,45)47-35-34-41(3,4)5)49-40(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3/t38-/m1/s1
| Molecular Formula | C40H80NO8P |
| Molecular Weight | 734.0389 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Colfosceril palmitate (dipalmitoylphosphatidylcholine) is a synthetic pulmonary surfactant, which is used in infants with respiratory distress syndrome it was approved in 1990, but nowadays it is under the state of canceled post-marketing. Colfosceril palmitate is reducing the tension and stabilizing the alveoli from collapsing.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. | 2005-04 |
|
| Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome. | 1994-12 |
|
| Unilateral pulmonary interstitial emphysema and treatment with colfosceril palmitate. | 1993-06-19 |
|
| Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome. | 1991-11 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:57:13 GMT 2025
by
admin
on
Mon Mar 31 17:57:13 GMT 2025
|
| Record UNII |
319X2NFW0A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
68492
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
||
|
WHO-VATC |
QR07AA01
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
||
|
LOINC |
2215-2
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
||
|
FDA ORPHAN DRUG |
14886
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
||
|
NCI_THESAURUS |
C78273
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
||
|
FDA ORPHAN DRUG |
29688
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
||
|
WHO-ATC |
R07AA01
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
69782
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
730
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
C47462
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
SUB22681
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
200-567-6
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
63-89-8
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
100000084265
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
319X2NFW0A
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
m3731
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB09114
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
C081581
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
CHEMBL1200737
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
452110
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
6728
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
107784
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
ALTERNATIVE | |||
|
319X2NFW0A
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
72999
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
SUB06799MIG
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
AA-82
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
40265
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
DTXSID5046720
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY | |||
|
COLFOSCERIL PALMITATE
Created by
admin on Mon Mar 31 17:57:13 GMT 2025 , Edited by admin on Mon Mar 31 17:57:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |